Watson Launches Authorized Generic of Prometrium

Watson Pharmaceuticals Inc. March 2 said it has launched an authorized generic version of Prometrium (progesterone) 100 mg and 200 mg capsules as part of an agreement with the drug’s manufacturer, Abbott Laboratories.

Prometrium is indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogen tablets, the Parsippany, N.J.-based company said. It also is indicated for use in secondary amenorrhea.

Under the terms of the supply agreement, Abbott manufactures and supplies Watson with all dosage strengths of the authorized generic product. Watson markets and distributes the product in the United States and ...